NASDAQ:LBRX • US50180M1080
ChartMill assigns a Buy % Consensus number of 86% to LBRX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-11 | Stifel | Maintains | Buy -> Buy |
| 2025-10-06 | Leerink Partners | Initiate | Outperform |
| 2025-10-06 | Stifel | Initiate | Buy |
| 2025-10-06 | Piper Sandler | Initiate | Overweight |
10 analysts have analysed LBRX and the average price target is 43.35 USD. This implies a price increase of 80.55% is expected in the next year compared to the current price of 24.01.
The consensus rating for LB PHARMACEUTICALS INC (LBRX) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.